Faculty Publications

Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)

Redman BG, Hudes GR, Kondagunta GV, Patel PH, Kim ST, Chen I, Motzer RJ

Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)

EJC Supplements. 2007 Sep;5(4):302.

Abstract

Last updated on Saturday, November 21, 2009